Drug intelligence / Profile preview

cyclophosphamide + fish oil + prednisone

Development stage
Unknown
Lead developer
Takeda
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

This is a combination therapy consisting of cyclophosphamide, fish oil (rich in omega-3 fatty acids), and prednisone. Cyclophosphamide is an alkylating agent used as an immunosuppressant and chemotherapeutic, primarily for autoimmune diseases and certain cancers. Prednisone is a synthetic glucocorticoid corticosteroid with potent anti-inflammatory and immunosuppressive properties. Fish oil, containing omega-3 fatty acids such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), has anti-inflammatory effects. This combination has been studied particularly in the treatment of proliferative lupus nephritis, where fish oil serves as an adjunct to enhance the efficacy of low-dose cyclophosphamide plus prednisone regimens by improving renal outcomes and reducing infection rates[1][2][4].

02

Targets

FFAR4 (Free fatty acid receptor 4)NaV (Voltage-gated sodium channels)GR (Glucocorticoid receptor)CACNA1C (Voltage-dependent L-type calcium channel subunit alpha-1C)DNA

Beyond the preview

Go deeper on cyclophosphamide + fish oil + prednisone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cyclophosphamide + fish oil + prednisone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call